Open AccessIntravenous -artemether formulation (ARM NLC) as a superior alternative to commercial artesunate formulation
Author(s) -
Sachinkumar Patil,
Medha Joshi,
Satish Pathak,
Sheel Sharma,
Vandana Patravale
Publication year - 2012
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dks293
Subject(s) - artemether , artesunate , pharmacology , medicine , chemistry , artemisinin , malaria , plasmodium falciparum , immunology
To compare the in vivo pharmacodynamic efficacy of intravenously administered artemether nanostructured lipid carrier (ARM NLC) with commercial artesunate (C-AST) at different dose levels.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom